Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · IEX Real-Time Price · USD
46.69
-0.13 (-0.28%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Ultragenyx Pharmaceutical Stock Forecast

Stock Price Forecast

The 12 analysts with 12-month price forecasts for RARE stock have an average target of 91.25, with a low estimate of 48 and a high estimate of 133. The average target predicts an increase of 95.44% from the current stock price of 46.69.

Analyst Consensus: Buy
Target Low Average Median High
Price $48 $91.25 $88 $133
Change +2.81% +95.44% +88.48% +184.86%

Analyst Ratings

The average analyst rating for RARE stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Oct '23Nov '23Dec '23Jan '24Feb '24Mar '24
Strong Buy 333233
Buy 776678
Hold 221111
Sell 000000
Strong Sell 000000
Total 12121091112

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
JP Morgan
JP Morgan
Buy
Maintains
$88$92
Buy Maintains $88$92 +97.04% Mar 18, 2024
JP Morgan
JP Morgan
Buy
Maintains
$84$88
Buy Maintains $84$88 +88.48% Feb 27, 2024
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Maintains
$107
Buy Maintains $107 +129.17% Feb 27, 2024
Canaccord Genuity
Canaccord Genuity
Strong Buy
Maintains
$110$111
Strong Buy Maintains $110$111 +137.74% Feb 21, 2024
Wedbush
Wedbush
Hold
Maintains
$47$48
Hold Maintains $47$48 +2.81% Feb 16, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
523.35M
from 434.25M
Increased by 20.52%
Revenue Next Year
662.03M
from 523.35M
Increased by 26.50%
EPS This Year
-6.58
from -8.25
EPS Next Year
-5.00
from -6.58
Year 2019202020212022202320242025202620272028
Revenue
103.71M271.03M351.41M363.33M434.25M523.35M662.03M862.23M1.59B2.37B
Revenue Growth
101.41%161.32%29.66%3.39%19.52%20.52%26.50%30.24%84.52%48.71%
EPS
-7.12-3.07-6.70-10.12-8.25-6.58-5.00-2.811.595.49
EPS Growth
---------244.87%
No. Analysts -----22201433
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 556.5M 966.7M 1.1B 2.5B 4.0B
Avg 523.4M 662.0M 862.2M 1.6B 2.4B
Low 489.7M 530.9M 621.3M 668.7M 799.0M

Revenue Growth

Revenue Growth 20242025202620272028
High
28.2%
84.7%
69.8%
194.7%
149.8%
Avg
20.5%
26.5%
30.2%
84.5%
48.7%
Low
12.8%
1.4%
-6.1%
-22.5%
-49.8%

EPS Forecast

EPS 20242025202620272028
High -5.49 -1.66 0.57 1.64 5.65
Avg -6.58 -5.00 -2.81 1.59 5.49
Low -7.96 -6.76 -5.81 1.53 5.27

EPS Growth

EPS Growth 20242025202620272028
High - - - -
255.0%
Avg - - - -
244.9%
Low - - - -
231.3%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.